13q34

13q34 is a cytogenetic band located on the long arm (q arm) of chromosome 13, spanning a region roughly from base pair 112 million to 115 million in the human reference genome. The designation “13q34” indicates that it is the 34th subband of the q arm, with the numbering reflecting the hierarchical subdivision used in karyotype banding patterns. In standard G‑banding, this area appears as a moderately dark region that can be distinguished from adjacent bands under light microscopy.

The 13q34 locus contains several protein‑coding genes and non‑coding elements. Notable genes that map to this band include SLC6A13, STXBP1, and IL1RAP, which are involved in neurotransmission, vesicle release, and immune signaling respectively. Additional genes within this region participate in cell cycle regulation, neuronal development, and metabolic pathways. Because of its gene density, alterations at 13q34 can disrupt multiple biological processes.

Clinically, changes in the 13q34 region are observed in a variety of disorders. Deletions involving 13q34 are a hallmark of the partial trisomy 13q deletion syndrome, which is associated with developmental delay, microcephaly, and congenital heart disease. Conversely, duplications of 13q34 have been reported in several solid tumors including medulloblastoma, colorectal carcinoma, and certain B‑cell lymphomas. Somatic mutations in specific 13q34 genes, such as those affecting signaling pathways, have been implicated in the pathogenesis of these cancers. In addition, mosaic deletions at this locus can lead to a phenotype comprising growth retardation and skeletal anomalies.

Detection of 13q34 alterations is typically performed by conventional cytogenetic analysis, fluorescence in situ hybridization (FISH) targeting band 13q34, or high‑resolution array comparative genomic hybridization (aCGH). Molecular techniques such as quantitative PCR and next‑generation sequencing can also identify submicroscopic deletions or point mutations within the band. Early identification of pathogenic variants in 13q34 facilitates accurate diagnosis, informs prognosis, and guides therapeutic decisions in both developmental disorders and oncology.